Bio

Ed Harvey is a veteran litigator and head of the Firm's Antitrust Practice Group. He frequently serves as lead antitrust counsel for clients across a broad range of industries. Drawing on his 40 years of experience in state and federal courts, as well as appellate courts, Ed formulates sophisticated litigation strategies that help clients overcome antitrust allegations and continue their business operations. Ed counsels clients on a wide range of antitrust matters, including Sherman Act and Clayton Act issues, price-discrimination matters, and trade association issues (including serving as antitrust counsel for national pharmaceutical trade association). He represents clients in obtaining Hart-Scott-Rodino pre-merger notification antitrust clearance. In his national antitrust practice, Ed represents clients in civil litigation, mergers and acquisitions, agency investigations, and class actions. Known for his novel approaches and dogged determination to outwork the other side, Ed's work for antitrust clients has derailed class actions, thrown out the expert testimony of a Nobel nominee, led to the rare survival of "Kodak"-style aftermarket counterclaims, and resulted in the denial of preliminary injunctions and the granting of dismissals and summary judgment in favor of our clients. Ed has extensive experience helping manufacturing clients navigate antitrust limitations on their distribution channels and strategies, and defends clients facing allegations of exclusive dealing, tying, resale price maintenance, price fixing, monopolization, and attempted monopolization. He helps companies successfully resolve Sherman Act Section 1 and 2 challenges to dealer agreements, as well as other claims regarding distribution arrangements. He also regularly provides antitrust counseling and evaluations regarding mergers and acquisitions, including advocacy for both buyers and sellers before the FTC and DOJ in Hart-Scott-Rodino reviews.